Systematic Reviews
Copyright ©The Author(s) 2022.
World J Psychiatry. Apr 19, 2022; 12(4): 623-635
Published online Apr 19, 2022. doi: 10.5498/wjp.v12.i4.623
Table 2 Summary of findings for included articles, organized by tumor subtypes
No.
Ref./country       
Tumor site
Number of participants/gender/age in years
Time since diagnosis
Parameters and tests (related to psychiatric disorders)
Key results: Prevalence of clinical levels of: Anxiety/depression/PTSD/comorbid anxiety-depression
Possible bias
1Alexander et al[26], 2010; United KingdomBreastn = 200; 100% female; mean: 58.1, range: 29-89Mean time since last treatment: 10.1 moEDS; HADS; SCID Depression: 9%; anxiety: 3.5%; comorbid: 1.5Selection bias; response bias
2Amir et al[28], 2002; IsraelBreastn = 39; 100% female; range: 37-60≥ 5 yrPTSD-scale; SCL-90Full PTSD: 18%; partial PTSD: 56% (additional)Selection bias; response bias
3Mehnert et al[25], 2008; GermanyBreastn = 1083; 100% female; mean: 61.8, range: 31-81Average: 47 moHADS; PCL-CModerate to high anxiety: 38% (high: 20.1%); moderate to high depression: 22% (high: 11.3%); PTSD: 12%Selection bias; response bias
4Qiu et al[42], 2012; ChinaBreastn = 505; 100% female; mean: 52.02Mean time after surgery: 17.6 moBDI; MINI Depression: 20.59%Response bias; performance bias
5Vazquez et al[16], 2020; United StatesBreastn = 700; 100% female; median: 37, range: 17-40144 d: HADS; 30 mo (PCL-S)PCL-S; HADSPTSS: 6.3%; depression: 8%; anxiety: 23%Selection bias; response bias
6Dahl et al[24], 2005; NorwayTesticularn = 1408; 100% male; mean: 44.6Mean: 11.3 yr HADSAnxiety: 19.2%; depression: 9.7%; comorbid: 6.8%Selection bias; response bias
7Dahl et al[17], 2016; NorwayTesticularn = 1418; 100% male; mean: 44.6Mean: 11 yrIESFull PTSD: 4.5%; partial PTSD: 6.4%; probable PTSD (combination of the 2): 10.9%Selection bias; response bias
8Fosså et al[43], 2003; NorwayTesticularn = 791; 100% male; median: 44, range: 23-75Median: 12 yrHADSAnxiety: 19%; depression: 9%Selection bias; response bias
9Thorsen et al[15], 2005; NorwayTesticularn = 1260; 100% male; median: 42Mean: 11 yearsHADSAnxiety: 20.2%; depression 9.7%Selection bias; response bias
10Vehling et al[19], 2016; GermanyTesticularn = 164; 100% male; mean: 44.4Mean: 11.6 yrGAD-7; PHQ-9Anxiety: 6.1%; depression: 7.9%Selection bias; response bias
11Chen et al[33], 2013; United StatesHead and neckn = 211; 58% male; median: 57, range: 21-93Disease free at least 1 yrUW-QOLDepression: 17% Response bias
12Lambert et al[21], 2005; United StatesHead and neckn = 694; 84.6% male; mean: 61.8At least 6 moGDS-SFDepression: 44.1%Selection bias; response bias
13Moschopoulou et al[44], 2018; United KingdomHead and neckn = 93; 58.1% male; mean: 66Mean: 6 yrPCL-CPTSD: 11.8%Selection bias; response bias
14Black et al[45], 2005; United KingdomHodgkin’s lymphoma non- Hodgkin’s lymphoma; acute leukemian = 36; 50% female; adults? - complete remissionPCL-CPTSD: 17%Selection bias; response bias
15Daniëls et al[46], 2014; The NetherlandsHodgkin’s lymphoman = 180; 55% male; median: 46Mean: 4.6 yrHADSAnxiety: 23%; depression: 18%Selection bias; response bias
16Geffen et al[35], 2003; IsraelHodgkin’s lymphoma; non-Hodgkin’s lymphomaHD: n = 8; nHL: n = 36; 46% male; median: 51; range: 27-80At least 2 yr after treatment completionPTSD-inventory scaleFull or partial PTSD: 32%; full PTSD: 18%; partial PTSD: 13% (additional)Selection bias; response bias
17Kuba et al[47], 2019; GermanyHematologicaln = 922; 57% male; range: 18-853 yrPHQ-9; GAD-7Anxiety: 9%; depression: 15%Selection bias; response bias
18Han et al[22], 2013; KoreaStomachn = 391; 72.9% male; mean: 54.5Mean (time since operation): 27.4 moBDIDepression: 43.9%Selection bias; response bias
19Hanprasertpong et al[48], 2017; ThailandCervical n = 700; 100% female; mean: 53Completion of treatment 3 mo - 10 yr before studyHADSAnxiety: 20.46%; depression: 9.44%Selection bias; response bias
20Urbaniec et al[18], 2011; AustraliaGynecologicaln = 45; 100% female; mean: 56.7, range: 23-83Mean: 4 yr; range: 0.9-11.6 yrBDI-II; SAI; IES-RevisedAnxiety: 28.9%; depression: 20%; probable PTSD: 15.6Selection bias; response bias
21Krajewski et al[49], 2018; GermanyMelanoman = 561; 51.2% male; mean: 62.14 yrHADSAnxiety: 10.2%; depression: 10.3%Selection bias; response bias
22Rogiers et al[27], 2020; BelgiumMelanoman =25; 28% male; median: 58, range: 28-86Median: 30 moSCID-IV-CV; HADSHADS: Anxiety: 32%; depression: 20%; comorbid: 12%. SCID: PTSD: 48%; depression: 0%Selection bias; response bias; performance bias
23Rogiers et al[14], 2020; BelgiumMelanoman = 17; 29% male; median: 57, range: 33-86Median: 5.6 yrSCID-IV-CV; HADSHADS: Anxiety: 35%; depression: 41%; comorbid: 30%. Interview: PTSD: 35%; depression: 11.76%Selection bias; response bias; performance bias
24Nicol et al[23], 2019; AustraliaBrainn = 65; 35.4% male; mean: 49.97; range: 22-75Mean: 5.29 yrDASS-Depression; GAD-7Anxiety: 58.5%; depression: 43.1%Selection bias; response bias
25Recklitis et al[50], 2014; United StatesProstaten = 693; 100% male; mean: 67.1Range: 3-8 yrGDS-15Depression: 15%Selection bias; response bias
26Uchitomi et al[51], 2003; JapanLungn = 212; 60.4% male; mean: 62.1, range: 22-831 mo after surgerySCID, Revised; POMS scaleDepression: 8%Selection bias; performance bias